Dr. Reddy's Laboratories Limited (RDY) Stock Overview
Explore Dr. Reddy's Laboratories Limited’s financial performance, market position, analyst ratings, and future outlook.
Dr. Reddy's Laboratories Limited (RDY)
Key Financials
Key Financials
Market Cap
12.4B
P/E Ratio
40.67
EPS (TTM)
$0.47
ROE
0.07%
RDY Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Dr. Reddy's Laboratories Limited (NYSE: RDY) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Dr. Reddy's Laboratories Limited's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of RDY on the NYSE shows an RSI of 72.96, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $12.87 for the NYSE listing.
Key metrics behind Dr. Reddy's Laboratories Limited's NYSE-traded stock include a P/E ratio of 40.67 and a market capitalization of 12.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of RDY on the NYSE.